India’s top and most valuable unlisted companies; Check the list below

Stocks or assets that aren’t traded on a public exchange are known as unlisted investments. The term “unquoted investments” is sometimes used to characterize them. The number of investors interested in buying unlisted shares has risen dramatically. In India, a large number of unlisted companies have formed, and their valuations are performing strongly. 

Here’s your introduction to the best unlisted companies! The top ten unlisted companies to watch out for in 2021-2022. (Source: Hurun Research Institute, 2021 Burgundy Private Hurun India 500)

• Serum Institute of India

Serum Institute Of India Private Limited is a non-public corporation that was founded on May 22, 1984. It is a private limited business with headquarters in Pune, Maharashtra. It has a total paid-up capital of INR 4.82 crore and an authorized share capital of INR 55.00 crore. The operating revenue range for Serum Institute Of India for the financial year ending March 31, 2021 is over INR 500 crore. Its EBITDA has increased by 53.49 percent in the last year. Its book networth has improved by 21.81 percent in the same period.

• National Stock Exchange of India

The NSE has a monopoly on stock derivatives and boasts operating margins of approximately 80% EBITDA (profits before interest, taxes, depreciation, and amortization) and a 93% operating to total income ratio. The NSE’s operating income increased by 60% to INR 5,625 crore in March 2021, compared to the previous year. Its net profit increased by 89 percent to INR 3,574 crore from INR 1,885 crore the year before. The sole flaw in NSE’s present value is that a portion of its net income came from a one-time stock sale in CAMS last year.

• Byju’s

Byju’s, the nation’s biggest education company, saw income doubled to INR 50 crore in 2020, with the majority of its revenues coming from the sale of SD cards, tablets and books. The tuition charge, sale of education tablets and SD cards, and sale of reference books all contributed to Byju’s standalone profits from operations of INR 2,110 crore.

• InMobi

InMobi Technology Services Private Limited recorded revenues of INR 432 crore for the financial year 2019-20, up 12% from the previous year. During the same fiscal year, the company also declared a net loss of INR 77 crore. Regulatory papers collected from corporate information platform Tofler revealed a 41% increase from the previous financial year. The Bengaluru-based mobile ad network reported INR 508 crore in total expenses for the fiscal year.

• OYO

Oravel Stays Limited reported a 54 percent drop in income year over year to INR 89 crore in fiscal 2020-21. During the fiscal year, the company reported a net loss of INR 241 crore, down from INR 326 crore in 2020. The hotel-booking company filed a DRHP with SEBI on October 1 for an initial public offering of INR 8,430 crore.

• Ramcharan & Co

On Wednesday, Ramcharan Co Pvt Ltd, a little-known Chennai-based corporation, received a $4.14 billion investment for its 46 percent interest from a foreign firm, bringing the company’s worth to over $9 billion. The reason for the increased valuation, why the investor TFCC’s India branch and the target company have the same addresses at Anna Salai in Chennai, why a fund is investing so much in an unknown waste-to-power technology, and what Ramcharan’s business is all about were some of the queries that arose.

• Dream11

Dream11, an online fantasy game platform, made a profit of INR 180 crore in the fiscal year 2020, making it one of the few profitable Indian consumer-tech unicorns. In 2019, it reported a loss of INR 87 crore. According to the latest regulatory documents received from business intelligence platform Tofler, Dream11, which is owned by Dream Sports, had its income climb by over 2.5 times to INR 2,070.4 crore in 2020 from INR 775.5 crore in 2019. It credited its sales growth to “innovative marketing methods” and “exciting new items,” according to the document.

• Macleods Pharmaceuticals

Macleods Pharmaceuticals Ltd is a private firm that was founded on June 5, 1989. It is a public limited company with headquarters in Mumbai, Maharashtra. It has a total paid-up capital of INR 19.96 crore and an authorized share capital of INR 25.00 crore. For the fiscal year ending March 31, 2020, Macleods Pharmaceuticals Ltd expects operational revenues of about INR 500 crore. Its EBITDA has increased by 42.13 percent in the last year. Its book networth has climbed by 28.92 percent in the same period.

• Intas Pharmaceuticals

Intas Pharmaceuticals Limited is a private firm that was founded on May 31, 1985. It is a public limited company with headquarters in Ahmedabad, Gujarat. It has a total paid-up capital of INR 114.77 crore and an authorized share capital of INR 175.47 crore. For the fiscal year ending March 31, 2021, Intas Pharmaceuticals Limited expects operational sales of around INR 500 crore. Its EBITDA has improved by 12.05 percent in the last year. Its book networth has climbed by 20.11 percent at the same time.

• Nirma

Nirma Limited is a private firm that was founded on February 25, 1980. It is a public limited company with headquarters in Ahmedabad, Gujarat. It has a total paid-up capital of INR 73.04 crore and an authorized share capital of INR 775.50 crore. For the fiscal year ending March 31, 2020, Nirma Limited expects operational sales of over INR 500 crore. The company’s EBITDA has dropped by -11.00% year over year. Its book networth has improved by 0.06 percent in the same period.

Disclaimer:

This blog is exclusively for educational purposes and does not provide any advice/tips on investment or recommend buying and selling any stock.